<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of <z:mp ids='MP_0005048'>thrombosis</z:mp> in the purely obstetric form of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> is uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>We performed a 10-year observational study of 1592 nonthrombotic women who had experienced 3 consecutive <z:hpo ids='HP_0005268'>spontaneous abortions</z:hpo> before the 10th week of gestation or 1 fetal <z:hpo ids='HP_0011420'>death</z:hpo> at or beyond the 10th week of gestation </plain></SENT>
<SENT sid="2" pm="."><plain>We compared the frequencies of thrombotic events among women positive for antiphospholipid Abs (n = 517), women carrying the F5 6025 or F2 rs1799963 polymorphism (n = 279), and women with negative <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> screening results (n = 796) </plain></SENT>
<SENT sid="3" pm="."><plain>The annual rates of <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> (1.46%; range, 1.15%-1.82%), <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> (0.43%; range, 0.26%-0.66%), superficial vein <z:mp ids='MP_0005048'>thrombosis</z:mp> (0.44%; range, 0.28%-0.68%), and cerebrovascular events (0.32%; range, 0.18%-0.53%) were significantly higher in aPLAbs women than in the other groups despite low-dose aspirin primary prophylaxis </plain></SENT>
<SENT sid="4" pm="."><plain>Women carrying 1 of the 2 polymorphisms did not experience more thrombotic events than women who screened negative for <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was a risk factor for unprovoked proximal and distal deep and superficial vein <z:mp ids='MP_0005048'>thrombosis</z:mp> and women in the upper quartile of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> activity had the highest risk </plain></SENT>
<SENT sid="6" pm="."><plain>Despite data suggesting that aPLAbs may induce pregnancy loss through nonthrombotic mechanisms, women with purely obstetric <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> are at risk for thrombotic complications </plain></SENT>
</text></document>